Skip to content

Impact of dexmedetomidine on postoperative biomarkers, length of hospitalisation and mortality in patients undergoing coronary artery bypass graft su

Impact of dexmedetomidine on postoperative biomarkers, length of hospitalisation and mortality in patients undergoing coronary artery bypass graft surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201806003460336
Enrollment
90
Registered
2018-06-12
Start date
2014-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System cardiovascular disease

Interventions

Dexmedetomidine
Saline

Sponsors

Palesa Mot
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Left main or triple vessel coronary artery disease. 2. Age above 18 and below 65 years.

Exclusion criteria

Exclusion criteria: 1. Age below 18 or above 65 years. 2. Pregnancy or lactation. 3. Liver dysfunction (AST or ALT > twice the upper range of normal). Normal values (National Health Laboratory Services: AST 5¿40 and ALT 5¿40 units/dl). 4. Sick sinus syndrome. 5. Use of concomitant medication with potential for major drug interactions such as propoxyphene, sodium oxybate and tinazide. 6. Patients requiring preoperative inotropic support. 7. Asthma. 8. Uncontrolled pulmonary congestion as evidenced radiologically and by arterial hypoxemia. 9. Evidence of ongoing infection as indicated by acute phase reaction markers. 10. Patients undergoing combined coronary and valve surgery, or other open heart procedures.

Design outcomes

Primary

MeasureTime frame
hs-cTnT

Secondary

MeasureTime frame
2. Length of ICU stay (days). ;3. Length of hospitalisation (days).;4. 30-day postoperative mortality.;5. 1-year mortality.

Countries

South Africa

Contacts

Public ContactChris Lundgren

Supervisor

chris.lundgren@wits.ac.za0119339334

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026